Elashry O M, Elbahnasy A M, Rao G S, Nakada S Y, Clayman R V
Department of Surgery (Division of Urologic Surgery), Washington University School of Medicine, St. Louis, Missouri 63110, USA.
J Urol. 1997 Jun;157(6):2074-80. doi: 10.1016/s0022-5347(01)64677-9.
Recent advances in the design of flexible ureteroscopes have resulted in smaller caliber instruments. We review our experience with the smaller flexible ureteroscopes, and compare the efficacy and efficiency of the newer 7.5F to the standard 9.3F flexible instruments.
Between January 1991 and 1995, 69 male and 41 female patients (mean age 57 years, range 16 to 91) underwent 116 retrograde flexible ureteroscopic procedures for a variety of diagnostic and therapeutic indications. A 9.3F ureteroscope (group 1) was used in 71 patients and a 7.5F instrument (group 2) was used in 39.
Patients in group 2 received sedation analgesia significantly more often than those in group 1 (56 versus 35%, p = 0.04). Active dilation of the ureteral orifice was required less often in group 2 (22.5%) than in group 1 (58%, p < or = 0.05). The total success rate for stone management, and diagnosis and/or treatment of an upper urinary tract lesion was 98.3 and 100%, respectively, in group 1, and 90 and 100%, respectively, in group 2 (p = 0.17). Of the 71 patients in group 1, 17 (24%) were treated on an outpatient basis, compared to 14 of 39 (49%) in group 2 (p = 0.16). No intraoperative or postoperative major complications were encountered in either group. Group 2 required less postoperative analgesia (p = 0.05). No ureteral stricture occurred in either group at an average followup of 9.5 months postoperatively (range 2 to 35).
For ureteral and renal pathological conditions the 7.5F ureteroscope is as effective as the 9.3F instrument diagnostically and therapeutically. The 7.5F ureteroscope usually can be used with sedation analgesia. Also, the smaller 7.5F ureteroscope is associated with less need for active ureteral dilation, minimal postoperative discomfort and a brief hospital stay.
柔性输尿管镜设计的最新进展已带来更小口径的器械。我们回顾了使用更小柔性输尿管镜的经验,并比较了新型7.5F柔性器械与标准9.3F柔性器械的疗效和效率。
1991年1月至1995年期间,69例男性和41例女性患者(平均年龄57岁,范围16至91岁)因各种诊断和治疗指征接受了116次逆行柔性输尿管镜检查。71例患者使用9.3F输尿管镜(第1组),39例使用7.5F器械(第2组)。
第2组患者比第1组患者更常接受镇静镇痛(56%对35%,p = 0.04)。第2组(22.5%)比第1组(58%,p≤0.05)更少需要主动扩张输尿管口。第1组结石处理以及上尿路病变诊断和/或治疗的总成功率分别为98.3%和100%,第2组分别为90%和100%(p = 0.17)。第1组71例患者中有17例(24%)门诊治疗,相比之下第2组39例中有14例(49%)(p = 0.16)。两组均未出现术中或术后严重并发症。第2组术后镇痛需求更少(p = 0.05)。术后平均随访9.5个月(范围2至35个月),两组均未发生输尿管狭窄。
对于输尿管和肾脏疾病,7.5F输尿管镜在诊断和治疗方面与9.3F器械同样有效。7.5F输尿管镜通常可在镇静镇痛下使用。此外,更小的7.5F输尿管镜需要主动输尿管扩张的需求更少,术后不适最小且住院时间短。